<DOC>
	<DOCNO>NCT00249964</DOCNO>
	<brief_summary>The purpose study determine maximum tolerable dose temozolomide combination fix dose paclitaxel carboplatin determine overall tumor response rate combination determine duration response .</brief_summary>
	<brief_title>Combination Paclitaxel , Carboplatin Temozolomide</brief_title>
	<detailed_description>The objective research study test combination drug treat small cell lung cancer spread beyond lung ( extensive cancer ) come back earlier treatment ( recurrent cancer ) .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>1 . Age great equal 18 year 2 . Karnofsky performance status ( KPS ) great equal 70 ( Appendix B ) 3 . Laboratory value ( perform within 14 day prior study drug administration , inclusive ) . 1 . Absolute neutrophil count ( ANC ) &gt; 1500/mm3 2 . Platelet count &gt; 100,000/mm3 3 . Hemoglobin &gt; 10 g/dl 100 g/l 4 . BUN serum creatinine &lt; 1.5 time upper limit laboratory normal 5 . Total direct bilirubin &lt; 1.5 time upper limit laboratory normal 6 . SGOT SGPT &lt; 3 time upper limit laboratory normal 7 . Alkaline Phosphatase &lt; 3 time upper limit laboratory normal 4 . A life expectancy great 12 week 5 . Subjects must give write informed consent . 6 . Biopsy proven small cell lung cancer . 7 . CT chest , abdomen , pelvis MRI head 8 . Patients brain metastasis asymptomatic enter study 1 . No recovery active toxicity prior therapy . 2 . Subjects poor medical risk nonmalignant systemic disease well acute infection treat intravenous antibiotic . 3 . Frequent vomit medical condition could interfere oral medication intake ( eg , partial bowel obstruction ) . 4 . Concurrent malignancy sit exception surgically cure carcinoma insite cervix basal squamous cell carcinoma skin . Prior malignancy require antitumor treatment within precede 24 month eligible . 5 . Known HIV positivity AIDSrelated illness . 6 . Pregnant nursing woman . 7 . Women childbearing potential use effective method contraception . Women childbearing potential must negative serum pregnancy test 24 hour prior administration study drug practice medically approve contraceptive precaution . 8 . Men advise use effective method contraception . 9 . Progression disease prior chemotherapy paclitaxel carboplatin , either single agent combination . 10 . Known hypersensitivity reaction taxoid platinum compound .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Extensive recurrent small cell lung cancer Phase I</keyword>
	<keyword>Paclitaxel , Carboplatin , Temozolomide</keyword>
</DOC>